Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Income from Continuing Operations (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Income from Continuing Operations for 13 consecutive years, with 4664000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 103.76% to 4664000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 13635000.0, a 27.09% decrease, with the full-year FY2025 number at 13635000.0, down 27.09% from a year prior.
  • Income from Continuing Operations was 4664000.0 for Q4 2025 at Ekso Bionics Holdings, down from 1420000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1420000.0 in Q3 2025 to a low of 4664000.0 in Q4 2025.
  • A 5-year average of 3471600.0 and a median of 3443500.0 in 2021 define the central range for Income from Continuing Operations.
  • Biggest YoY gain for Income from Continuing Operations was 47.76% in 2025; the steepest drop was 103.76% in 2025.
  • Ekso Bionics Holdings' Income from Continuing Operations stood at 4588000.0 in 2021, then rose by 1.87% to 4502000.0 in 2022, then grew by 21.92% to 3515000.0 in 2023, then skyrocketed by 34.88% to 2289000.0 in 2024, then crashed by 103.76% to 4664000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Income from Continuing Operations are 4664000.0 (Q4 2025), 1420000.0 (Q3 2025), and 4039000.0 (Q2 2025).